CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 38 enrolled
Drug / intervention
Finesse +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01073566
NCT01073566Phase 2Completed
CompareCT.gov

The Effects of Finesse on Glycemic Control in Adults With Diabetes Using MDI: Finesse vs. Pen or Syringe and Vial as Bolus Prandial Insulin Device

Calibra Medical, Inc.·interventional·Posted Feb 23, 2010·Updated Feb 4, 2025

In Brief

A Phase 2 clinical trial evaluating Finesse and Pen/Syringe (Usual injection device) for Diabetes Mellitus. Completed, enrolled 38 participants across 5 sites.

Detailed Summary

The purpose of this study is to evaluate that Finesse, for prandial insulin bolusing when used in conjunction with basal insulin, achieves equivalent glycemic control when compared to multiple daily injections and to evaluate its preference.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
CollaboratorsNancy Bohannon, MD, Med. Corp., Henry Ford Health System, Northwestern University, University of Texas Southwestern Medical Center, International Diabetes Center at Park Nicollet

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 23, 2010
Enrollment StartJan 1, 2010
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.4 years ago

Interventions

Finessedevice

Finesse Insulin Delivery Patch

Pen/Syringe (Usual injection device)device

Pen/Syringe